Structure of Esomeprazole sodium
CAS No.: 161796-78-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Esomeprazole sodium, the sodium salt of esomeprazole which has the effect of reducing gastric acid secretion.
Synonyms: (S)-Omeprazole sodium; (-)-Omeprazole sodium; Esomeprazole(sodium)
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 161796-78-7 |
| Formula : | C17H18N3NaO3S |
| M.W : | 367.40 |
| SMILES Code : | O=[S@](C1=NC2=CC=C(OC)C=C2[N-]1)CC3=NC=C(C)C(OC)=C3C.[Na+] |
| Synonyms : |
(S)-Omeprazole sodium; (-)-Omeprazole sodium; Esomeprazole(sodium)
|
| MDL No. : | MFCD07802816 |
| GHS Pictogram: |
|
| Signal Word: | Danger |
| Hazard Statements: | H302-H315-H318-H335-H410 |
| Precautionary Statements: | P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P362+P364-P403+P233-P501 |
| Class: | 9 |
| UN#: | 3077 |
| Packing Group: | Ⅲ |
| Description |
Esomeprazole sodium ((S)-Omeprazole sodium) is a powerful and orally active inhibitor of the proton pump, decreasing acid production by targeting the H+, K+-ATPase in the gastric parietal cells. Furthermore, Esomeprazole sodium impedes exosome release by inhibiting V-H+-ATPases, acting as an exosome inhibitor[4].
|
| Target |
|
In Vitro:
| Concentration | Treated Time | Description | References |
| Jurkat cells | 5 μM | 72 h | Inhibit H+-ATPase activity and regulate intracellular pH | Immunity. 2023 Dec 12;56(12):2682-2698.e9. |
| Het-1A cells | 30 µM | 6 h | To evaluate the effect of Esomeprazole on HCl-induced inflammatory responses. Results showed that Esomeprazole significantly inhibited the HCl-induced elevation of pro-inflammatory cytokines (IL-6, IL-8, IL-1β, TNF-α). | Front Immunol. 2024 Dec 16;15:1410904. |
| Human cord blood-derived mast cells | 50μM | 2 h | To evaluate the effect of omeprazole on human mast cell degranulation and cytokine secretion. Results showed that omeprazole significantly inhibited LAMP-1 expression and histamine release. | J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5. |
| Bone marrow-derived mast cells | 50μM | 2 h | To evaluate the effect of omeprazole on IgE-mediated mast cell degranulation and cytokine secretion. Results showed that omeprazole significantly inhibited LAMP-1 expression and histamine release. | J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5. |
| IPF lung fibroblasts | 100 μM | 24 h | To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced collagen production. Results showed that the combination therapy significantly suppressed collagen production. | Sci Rep. 2022 Nov 30;12(1):20668. |
| IPF lung fibroblasts | 100 μM | 48 h | To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced collagen gel contraction. Results showed that the combination therapy effectively inhibited collagen gel contraction. | Sci Rep. 2022 Nov 30;12(1):20668. |
| IPF lung fibroblasts | 100 μM | 72 h | To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced cell migration. Results showed that the combination therapy was more effective in inhibiting cell migration than monotherapy. | Sci Rep. 2022 Nov 30;12(1):20668. |
| IPF lung fibroblasts | 100 μM | 24 h | To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced cell proliferation. Results showed that esomeprazole significantly enhanced the anti-proliferative effect of pirfenidone. | Sci Rep. 2022 Nov 30;12(1):20668. |
| Human esophageal adenocarcinoma cell line OE19 | 50 μM, 200 μM, 350 μM | 72 h | To evaluate the effect of esomeprazole on OE19 cell survival, showing dose-dependent inhibition of cell survival | J Exp Clin Cancer Res. 2014 Sep 1;33(1):73. |
| Human esophageal squamous cell carcinoma cell line KYSE410 | 50 μM, 250 μM, 350 μM | 72 h | To evaluate the effect of esomeprazole on KYSE410 cell survival, showing dose-dependent inhibition of cell survival | J Exp Clin Cancer Res. 2014 Sep 1;33(1):73. |
In Vivo:
| Administration | Dosage | Frequency | Description | References |
| Sprague-Dawley rats | Intragastric administration model | Intragastric administration | 50 pellets | Single dose, lasting 2 hours | Observe the structural changes of esomeprazole magnesium enteric-coated pellets in the stomach. Results showed that the retention rate of pellets in the stomach after 2 hours was 38.97%, and the sphericity, pellet volume, pore volume, and porosity were 0.47, 1.55×10^8 mm3, 0.44×10^8 mm3, and 27.6%, respectively. | Acta Pharm Sin B. 2022 Jan;12(1):326-338 |
| BALB/c mice | Whole-brain irradiation injury model | Intraperitoneal injection | 10 mg/kg | Once daily for 8 weeks | Inhibited AEP’s enzymatic activity and alleviated radiation-induced brain injury | iScience. 2024 Apr 9;27(5):109698 |
| Mice | Radiation-induced brain injury model | Intraperitoneal injection | 10 mg/kg | Once daily for 8 weeks | Inhibited the enzymatic activity of AEP and alleviated radiation-induced brain injury | iScience. 2024 Apr 9;27(5):109698 |
| BALB/c mice | Passive systemic anaphylaxis model | Intraperitoneal injection | 1.6mg/0.2mL | 4 consecutive days | To evaluate the effect of esomeprazole on IgE-mediated systemic anaphylaxis. Results showed that esomeprazole significantly reduced the drop in core body temperature and release of MCPT-1 and histamine. | J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5. |
| C57BL/6J mice | TGFβ-induced lung fibrosis model | Oral gavage | 30 mg/kg | Daily administration for 28 days | To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced lung fibrosis. Results showed that the combination therapy was more effective in suppressing lung fibrosis and αSMA expression than monotherapy. | Sci Rep. 2022 Nov 30;12(1):20668. |
| Mice | Clostridioides difficile infection model | Oral gavage | 40 mg/kg | Five times per 12 h interval | Used to induce Clostridioides difficile infection model, results showed Esomeprazole pretreatment increased infection risk. | Bioeng Transl Med. 2023 Sep 5;8(6):e10593 |
| Mice | B16-F10 melanoma model | Intraperitoneal injection | 12.5 mg/kg | Every other day for a total of 6 injections | Neutralize tumor microenvironment acidic pH and improve T cell function | Immunity. 2023 Dec 12;56(12):2682-2698.e9. |
| Mice | Autism spectrum disorder model | Oral | 50 mg/kg | 4 weeks | To investigate the effects of p-Cresol on ASD-like behaviors in mice, results showed p-Cresol induced social behavior deficits and stereotypies | Microbiome. 2021 Jul 8;9(1):157 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT03383003 | Helicobacter Pylori Infection | Not Applicable | Completed | - | Taiwan ... More >> Wei-Chen Tai Kaohsiung, Taiwan, 833 Less << |
| NCT02711176 | Helicobacter Infection | Phase 4 | Completed | - | Iran, Islamic Republic of ... More >> Ilam University of Medical Scienvc Ilam, Iran, Islamic Republic of, 6939177143 Less << |
| NCT03444402 | GERD | Phase 1 | Completed | - | Korea, Republic of ... More >> Seoul University Hospital Seoul, Korea, Republic of Less << |
| NCT02197039 | - | Unknown | July 2016 | Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Hsiu-Chi Cheng, MD, PhD 886-6-2353535 ext 4733 teishuki@mail.ncku.edu.tw Principal Investigator: Hsiu-Chi Cheng, MD, PhD Less << | |
| NCT00881413 | Peptic Ulcer | Phase 4 | Withdrawn(problems in funding) | - | - |
| NCT03488147 | Dysphagia GER... More >>D Degenerative Joint Disease Less << | Phase 2 | Not yet recruiting | April 2, 2020 | United States, New York ... More >> Mount Sinai West Not yet recruiting New York, New York, United States, 10019 Principal Investigator: Andrew C Hecht, MD Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Principal Investigator: Andrew C Hecht, MD Less << |
| NCT00444236 | Exercise Triggered Asthma ... More >> Gastroesophageal Reflux Less << | Phase 1 | Terminated(The sponsor decided... More >> to terminate the study due to slow enrollment.) Less << | - | United States, Utah ... More >> University of Utah Health Sciences Center Salt Lake City, Utah, United States, 84132 Less << |
| NCT01761513 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Yonsei University Health System(Severance Hospital) Seoul, Seodaemun-gu,Sinchon-dong, Korea, Republic of, 120-752 Less << |
| NCT00251966 | Gastroesophageal Reflux | Phase 3 | Completed | - | - |
| NCT00123656 | Esophagitis | Phase 2 | Completed | - | United States, Utah ... More >> University of Utah HSC Salt Lake City, Utah, United States, 84132 Less << |
| NCT01669811 | Refractory Reflux Esophagitis | Phase 3 | Completed | - | - |
| NCT02553083 | Bacterial Infection Due to Hel... More >>icobacter Pylori (H. Pylori) Less << | Phase 4 | Recruiting | December 2021 | Israel ... More >> Rabin Medical Center Recruiting Petach Tikva, Israel, 49100 Contact: Yaron Niv, MD 97239377237 yniv@clalit.org.il Principal Investigator: Yaron Niv, MD Less << |
| NCT00079833 | Zollinger-Ellison Syndrome | Phase 3 | Completed | - | United States, California ... More >> Research Site Los Angeles, California, United States United States, Florida Research Site Gainesville, Florida, United States United States, Ohio Research Site Columbus, Ohio, United States United States, Pennsylvania Research Site King of Prussia, Pennsylvania, United States Research Site Philadelphia, Pennsylvania, United States France Research Site Clichy, France Research Site Paris, France Research Site Saint Germain en Laye, France Less << |
| NCT02794844 | Gastroesophageal Reflux | Phase 4 | Completed | - | United States, Florida ... More >> Nemours Children's Hospital Orlando, Florida, United States, 32827 Less << |
| NCT03040817 | Gastric Peroral Endoscopic Pyl... More >>oromyotomy (G-POEM) Less << | Not Applicable | Recruiting | December 16, 2019 | China, Jiangsu ... More >> Zhongda Hospital Southeast University Recruiting Nanjing, Jiangsu, China Contact: Ruihua Shi ruihuashi@126.com Less << |
| NCT02794844 | - | Completed | - | - | |
| NCT00241501 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 3 | Completed | - | - |
| NCT00625274 | Heartburn Upp... More >>er Abdominal Pain Nausea Acid Regurgitation Less << | Phase 4 | Completed | - | - |
| NCT02708355 | - | Completed | - | - | |
| NCT01089959 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 2 Phase 3 | Unknown | March 2012 | United States, Arizona ... More >> Southern Arizona VA Health Care System Recruiting Tucson, Arizona, United States, 85723 Contact: Ronnie Fass, MD 520-792-1450 ext 5139 ronniefass@va.gov Principal Investigator: RONNIE FASS, MD Less << |
| NCT02197143 | Dyspepsia | Phase 4 | Completed | - | Turkey ... More >> Pamukkale Universty Denizli, Turkey, 20000 Less << |
| NCT01669811 | - | Completed | - | - | |
| NCT00251992 | Gastrointestinal Disease ... More >> Signs and Symptoms, Digestive Dyspepsia Less << | Phase 3 | Completed | - | - |
| NCT00251914 | Gastrointestinal Disease ... More >> Signs and Symptoms, Digestive Dyspepsia Less << | Phase 3 | Completed | - | - |
| NCT00951431 | Nonulcer Dyspepsia | Phase 4 | Unknown | December 2011 | Hong Kong ... More >> Prince of Wales Hospital Recruiting Hong Kong, Hong Kong Principal Investigator: Justin C.Y. Wu, MBChB(CUHK) Less << |
| NCT03558477 | GERD | Phase 1 | Completed | - | Korea, Republic of ... More >> Kyungpook national university hospital Daegu, Korea, Republic of Less << |
| NCT02708355 | Heartburn | Phase 4 | Completed | - | United States, Oklahoma ... More >> Oklahoma Foundation for Digestive Research Oklahoma City, Oklahoma, United States, 73102 St. Anthony Hospital - Conference Rooms Oklahoma City, Oklahoma, United States, 73102 Less << |
| NCT00164788 | Gastrointestinal Hemorrhage | Phase 2 | Terminated(No suitable patient... More >>s and many patients refused the study) Less << | - | China ... More >> Endoscopy Center, Prince of Wales Hospital Hong Kong (SAR), China Less << |
| NCT02476097 | Stomach Diseases | Phase 4 | Recruiting | December 2018 | Switzerland ... More >> Service de de médecine interne et de rehabilitation, Beau-séjour, HUG Recruiting Genève, Switzerland Contact: Jules Desmeules, Pr 41(0)22 23 05 53 87 Principal Investigator: Jules Desmeules, Pr Service de réadaptation de l'appareil locomoteur Clinique romande de réadaptation, Sion Recruiting Sion, Switzerland Contact: Lucien Roulet, Pharm D lucien.roulet@hopitalvs.ch Less << |
| NCT00069823 | Asthma Lung D... More >>iseases Lung Diseases, Obstructive Less << | Phase 3 | Completed | - | - |
| NCT00230516 | Healthy | Phase 4 | Completed | - | United States, California ... More >> Research Site Los Angeles, California, United States United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States Less << |
| NCT00069823 | - | Completed | - | - | |
| NCT00628342 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 4 | Completed | - | - |
| NCT00361985 | Anastomotic Stricture ... More >> Morbid Obesity Less << | Phase 4 | Withdrawn(Insufficient enrollm... More >>ent) Less << | - | United States, New York ... More >> Weill Medical College of Cornell Unversity New York, New York, United States, 10021 Less << |
| NCT01123031 | Upper Gastrointestinal Bleedin... More >>g Less << | Phase 4 | Unknown | April 2011 | - |
| NCT00444275 | GERD | Phase 4 | Completed | - | France ... More >> Research Site Rouen, France Less << |
| NCT00628667 | Chronic Posterior Laryngitis (... More >>CPL) Less << | Phase 4 | Completed | - | - |
| NCT00222079 | Gastro-esophageal Reflux | Not Applicable | Terminated(Project canceled du... More >>e to the implementation of IMRT, fewer patients reporting xerostomia.) Less << | - | United States, Iowa ... More >> University of Iowa Department of Otolaryngology Iowa City, Iowa, United States, 52242 Less << |
| NCT00444275 | - | Completed | - | - | |
| NCT00574925 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 4 | Completed | - | Switzerland ... More >> University Hospital Zurich Zurich, Switzerland Less << |
| NCT00728481 | Eosinophilic Esophagitis ... More >> Gastroesophageal Reflux Disease EE GERD Less << | Phase 2 Phase 3 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT01275937 | Upper Gastrointestinal Bleedin... More >>g Less << | Phase 4 | Unknown | January 2014 | Taiwan ... More >> Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Hwai-jeng Lin, M.D. 886-2-27372181 ext 3040 buddhistlearning@gmail.com Principal Investigator: Hwai-jeng Lin, M.D. Less << |
| NCT00644735 | Erosive Esophagitis | Phase 4 | Completed | - | - |
| NCT00728481 | - | Completed | - | - | |
| NCT00626535 | Symptomatic Gastroesophageal R... More >>eflux Disease (sGERD) Less << | Phase 3 | Completed | - | - |
| NCT00612027 | - | Completed | - | - | |
| NCT00332748 | Cancer | Phase 1 | Terminated | - | United States, Delaware ... More >> Local Institution Newark, Delaware, United States United States, Kentucky Local Institution Louisville, Kentucky, United States United States, Nevada Local Institution Las Vegas, Nevada, United States Netherlands Local Institution Amsterdam, Netherlands Less << |
| NCT03315676 | Gastrointestinal Erosions and/... More >>or Ulcers Less << | Phase 2 | Recruiting | September 4, 2020 | Japan ... More >> Yukio Nakamura Recruiting Matsumoto, Nagano, Japan, 3908621 Contact: Yukio Nakamura, MD, PhD +81-263-37-2659 yxn14@aol.jp Principal Investigator: Yukio Nakamura, MD, PhD Less << |
| NCT00317044 | - | Completed | - | - | |
| NCT02277886 | Gastroesophageal Reflux Diseas... More >>e Heartburn Sleep Disturbance Less << | Phase 4 | Unknown | June 2016 | Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taipei, Taiwan, 105 Contact: Cheng-Tang Chiu, MD +886-3-3281200 ext 8101 stacey@adm.cgmh.org.tw Contact: Johnny Chu, PhD +886-2-25090464 ext 4280 johnnychu@tty.com.tw Principal Investigator: Cheng-Tang Chiu, MD Less << |
| NCT00474019 | Pharmacokinetics | Phase 1 | Completed | - | United States, Arkansas ... More >> Research Site Little Rock, Arkansas, United States United States, Connecticut Research Site Hartford, Connecticut, United States United States, Illinois Research Site Park Ridge, Illinois, United States United States, Kentucky Research Site Louisville, Kentucky, United States United States, Michigan Research Site Detroit, Michigan, United States Research Site Southfield, Michigan, United States United States, New Jersey Research Site New Brunswick, New Jersey, United States United States, New York Research Site Buffalo, New York, United States United States, Ohio Research Site Cleveland, Ohio, United States United States, Texas Research Site Fort Worth, Texas, United States Research Site Houston, Texas, United States Australia, South Australia Research Site North Adelaide, South Australia, Australia Belgium Research Site Brussels (jette), Belgium Hungary Research Site Budapest, Hungary Sweden Research Site Goteborg, Sweden Less << |
| NCT00317044 | Asthma GERD | Phase 2 | Completed | - | - |
| NCT02543606 | Healthy | Phase 4 | Completed | - | Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan, 40705 Less << |
| NCT00660660 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 4 | Completed | - | - |
| NCT00684190 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 1 | Completed | - | Sweden ... More >> Research Site Uppsala, Sweden Less << |
| NCT00660660 | - | Completed | - | - | |
| NCT00629564 | GERD | Phase 4 | Completed | - | - |
| NCT00633412 | NSAID Associated Gastric Ulcer... More >>s Less << | Phase 3 | Completed | - | - |
| NCT00287339 | - | Completed | - | - | |
| NCT00225238 | Nausea Vomiti... More >>ng Abdominal Pain Less << | Phase 4 | Completed | - | United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
| NCT00287339 | Cough GERD | Phase 4 | Completed | - | United States, North Carolina ... More >> UNC Gastroenterology, UNC Pulmonology, UNC ENT Chapel Hill, North Carolina, United States, 27599 Less << |
| NCT00628953 | Asthma | Phase 2 | Completed | - | - |
| NCT00318968 | GERD | Phase 4 | Completed | - | Denmark ... More >> Research Site Aabenraa, Denmark Research Site Aalborg, Denmark Research Site Albek, Denmark Research Site Alborg, Denmark Research Site Ans by, Denmark Research Site Arhus C, Denmark Research Site Bagsverd, Denmark Research Site Birkerod, Denmark Research Site Bronshoj, Denmark Research Site Farum, Denmark Research Site Fredericia, Denmark Research Site Frederikshavn, Denmark Research Site Frederikssund, Denmark Research Site Grasten, Denmark Research Site Haslev, Denmark Research Site Herning, Denmark Research Site Hinnerup, Denmark Research Site Karlslunde, Denmark Research Site Kerteminde, Denmark Research Site Kobenhavn K, Denmark Research Site Kolding, Denmark Research Site Losning, Denmark Research Site Middelfart, Denmark Research Site Nestved, Denmark Research Site Odense C, Denmark Research Site Randers, Denmark Research Site Rodovre, Denmark Research Site Roskilde, Denmark Research Site Rungsted Kyst, Denmark Research Site Saltum, Denmark Research Site Seby, Denmark Research Site Sindal, Denmark Research Site Solrod Strand, Denmark Research Site Svendborg, Denmark Research Site Tastrup, Denmark Research Site Tonder, Denmark Research Site Ullerslev, Denmark Research Site Viborg, Denmark Research Site Viby J, Denmark Less << |
| NCT00216788 | Reflux Esopha... More >>gitis Barrett's Esophagus Less << | Phase 1 | Unknown | January 2006 | United States, Pennsylvania ... More >> Lankenau Hospital Not yet recruiting Wynnewood, Pennsylvania, United States, 19096 Contact: Daniel Lazowick, D.O. 610-645-6555 Sub-Investigator: Daniel Lazowick, D.O. Less << |
| NCT00295685 | GERD | Phase 4 | Completed | - | United States, Virginia ... More >> Digestive & Liver Disease Specialists Norfolk, Virginia, United States, 23502 Less << |
| NCT02444507 | Healthy Adult Subjects | Phase 4 | Unknown | June 2015 | Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung City, Taiwan, 40705 Contact: Yeh Hong Zen, Physician 886-919085331 yhz@vghtc.gov.tw Sub-Investigator: Chen Chia Chang, Physician Less << |
| NCT00635414 | GERD | Phase 4 | Completed | - | - |
| NCT00637988 | Barrett's Esophagus | Phase 4 | Completed | - | - |
| NCT00251927 | Gastroesophageal Reflux | Phase 3 | Completed | - | - |
| NCT02494856 | Pain Other Su... More >>rgical Procedures Impacted Third Molar Tooth Less << | Phase 4 | Completed | - | Brazil ... More >> University of São Paulo Bauru, SP, Brazil, 17012-901 Less << |
| NCT01130935 | - | Completed | - | Albania ... More >> Research Site Berat, Albania Research Site Burrel, Albania Research Site Durres, Albania Research Site Elbasan, Albania Research Site Fier, Albania Research Site Kavaje, Albania Research Site Korce, Albania Research Site Kruje, Albania Research Site Lezhe, Albania Research Site Lushnje, Albania Research Site Peshkopi, Albania Research Site Shkoder, Albania Research Site Tirane, Albania Research Site Vlore, Albania Less << | |
| NCT00443963 | Dyspepsia | Phase 4 | Terminated(The Principal Inves... More >>tigator is no longer affiliated with the Study Site.) Less << | - | United States, District of Col... More >>umbia Washington Hospital Center 110 Irving St. NW, Washington, District of Columbia, United States, 20010 Less << |
| NCT01591083 | Peptic Ulcer Bleeding | Phase 4 | Completed | - | Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan, 704 Less << |
| NCT01153659 | Healthy | Phase 1 | Completed | - | United States, Oklahoma ... More >> Oklahoma Foundation for Digestive Research Oklahoma City, Oklahoma, United States, 73104 Less << |
| NCT00405119 | Gastroesophageal Reflux Diseas... More >>e Reflux, Gastroesophageal Less << | Phase 2 | Completed | - | Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4006 Less << |
| NCT00629512 | NSAID Associated Gastric Ulcer... More >>s Less << | Phase 3 | Completed | - | - |
| NCT00629928 | NSAID Associated Gastric Ulcer... More >>s Less << | Phase 3 | Completed | - | - |
| NCT00251927 | - | Completed | - | - | |
| NCT03211143 | GERD | Phase 1 | Completed | - | Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less << |
| NCT01199328 | Healthy Volunteers | Phase 1 | Completed | - | United States, Missouri ... More >> Research Site Springfield, Missouri, United States Less << |
| NCT00206024 | Heartburn | Phase 4 | Completed | - | - |
| NCT00318084 | GERD | Phase 4 | Completed | - | Netherlands ... More >> Research Site Utrecht, Netherlands Less << |
| NCT00474903 | - | Completed | - | - | |
| NCT00474903 | Barrett Esophagus ... More >> Esophageal Cancer Less << | Phase 2 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT00184522 | Gastroesophageal Reflux | Phase 4 | Completed | - | Norway ... More >> Gjøvik Specialist Centre Gjøvik, Norway, 2800 Sykehuset Innlandet HF, Gjøvik Gjøvik, Norway, 2819 Sykehuset Innlandet HF, Hamar Hamar, Norway Sykehuset Innlandet HF, Kongsvinger Kongsvinger, Norway Sykehuset Innlandet HF, Lillehammer Lillehammer, Norway Helse Nord-Møre og Romsdal Molde, Norway Mosjøen sykehus Mosjøen, Norway Helse Nord-Trøndelag Namsos, Norway Sykehuset Innlandet HF, Tynset Tynset, Norway Less << |
| NCT01471925 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 3 | Withdrawn(Change company strat... More >>egy) Less << | - | Brazil ... More >> Instituto Goiano de Gastroenterologia Goiania, GO, Brazil Mãe de Deus Center Porto Alegre, Rio Grande do Sul, Brazil Centro de pesquisa Clínica do Serviço de gastroenterologia Rio de janeiro, RJ, Brazil Hospital Israelita Albert Einstein São Paulo, SP, Brazil Centro de Pesquisa Clínica de Campinas Canpinas, São Paulo, Brazil Centro de Estudos Clínicos do Interior Paulista Jaú, São Paulo, Brazil Less << |
| NCT03562026 | - | Recruiting | December 31, 2020 | Japan ... More >> Research Site Recruiting Aichi, Japan Research Site Not yet recruiting Aichi, Japan Research Site Recruiting Akita, Japan Research Site Recruiting Chiba, Japan Research Site Not yet recruiting Chiba, Japan Research Site Recruiting Ehime, Japan Research Site Active, not recruiting Ehime, Japan Research Site Recruiting Fukui, Japan Research Site Recruiting Fukuoka, Japan Research Site Not yet recruiting Fukuoka, Japan Research Site Recruiting Gifu, Japan Research Site Not yet recruiting Gifu, Japan Research Site Active, not recruiting Gunma, Japan Research Site Recruiting Hiroshima, Japan Research Site Not yet recruiting Hiroshima, Japan Research Site Recruiting Hokkaido, Japan Research Site Recruiting Hyogo, Japan Research Site Not yet recruiting Hyogo, Japan Research Site Recruiting Ibaraki, Japan Research Site Not yet recruiting Iwate, Japan Research Site Recruiting Kagawa, Japan Research Site Recruiting Kagoshima, Japan Research Site Active, not recruiting Kanagawa, Japan Research Site Recruiting Kanagawa, Japan Research Site Not yet recruiting Kanagawa, Japan Research Site Recruiting Kumamoto, Japan Research Site Not yet recruiting Kyoto, Japan Research Site Recruiting Mie, Japan Research Site Recruiting Miyagi, Japan Research Site Active, not recruiting Miyagi, Japan Research Site Recruiting Nagano, Japan Research Site Active, not recruiting Nagano, Japan Research Site Not yet recruiting Okayama, Japan Research Site Recruiting Osaka, Japan Research Site Not yet recruiting Osaka, Japan Research Site Recruiting Saitama, Japan Research Site Recruiting Shizuoka, Japan Research Site Recruiting Tochigi, Japan Research Site Active, not recruiting Tokushima, Japan Research Site Recruiting Tokyo, Japan Research Site Not yet recruiting Tokyo, Japan Research Site Recruiting Toyama, Japan Research Site Recruiting Yamagata, Japan Less << | |
| NCT00633672 | NSAID Associated Gastric Ulcer... More >>s Less << | Phase 3 | Completed | - | - |
| NCT00626262 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 4 | Completed | - | - |
| NCT00734097 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 4 | Completed | - | Argentina ... More >> Research Site Buenos Aires, Argentina Chile Research Site Santiago de Chile, Chile Research Site Temuco, Chile Research Site Vina del Mar, Chile Colombia Research Site Barranquilla, Colombia Research Site Bogota, Colombia Research Site Medellin, Colombia Venezuela Research Site Barquisimeto, Venezuela Research Site Caracas, Venezuela Research Site San Cristobal, Venezuela Less << |
| NCT00734097 | - | Completed | - | - | |
| NCT01562600 | - | Completed | - | Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less << | |
| NCT01729182 | - | Completed | - | Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less << | |
| NCT00637559 | Barrett's Esophagus | Phase 4 | Completed | - | - |
| NCT02680119 | Healthy | Phase 1 | Completed | - | - |
| NCT00625495 | Gastroesophageal Reflux Diseas... More >>e Less << | Phase 4 | Completed | - | - |
| NCT01435525 | - | Completed | - | Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tokyo, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamanashi, Japan Less << | |
| NCT00206440 | Nausea | Phase 3 | Terminated(Accrual was not opt... More >>imized) Less << | - | United States, Texas ... More >> Baylor Breast Center Houston, Texas, United States, 77030 Less << |
| NCT01434485 | - | Completed | - | Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less << | |
| NCT01562639 | - | Completed | - | Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less << | |
| NCT00206180 | Erosive Esophagitis ... More >> Reflux Esophagitis Gastroesophageal Reflux Disease Less << | Phase 4 | Completed | - | - |
| NCT00687245 | Endoscopically-Proven GERD ... More >> Reflux Less << | Phase 1 | Completed | - | - |
| NCT00641602 | Erosive Esophagitis | Phase 4 | Completed | - | - |
| NCT00428701 | Gastric Ulcer | Phase 4 | Completed | - | United States, Delaware ... More >> Research SIte Newark, Delaware, United States United States, Louisiana Research Site Shreveport, Louisiana, United States United States, Pennsylvania Research Site Hershey, Pennsylvania, United States United States, Tennessee Research Site Memphis, Tennessee, United States Research Site Nashville, Tennessee, United States Less << |
| NCT00699426 | Type 2 Diabetes | Phase 3 | Completed | - | - |
| NCT02680132 | Healthy | Phase 1 | Completed | - | - |
| NCT00206440 | - | Terminated(Accrual was not opt... More >>imized) Less << | - | - | |
| NCT01129713 | Gastroesophageal Reflux Diseas... More >>e (GERD) Heartburn Indigestion Less << | Phase 1 Phase 2 | Unknown | May 2015 | United States, Arizona ... More >> Southern Arizona Veterans Health Care System Recruiting Tucson, Arizona, United States, 85723 Principal Investigator: Ronnie Fass, MD Less << |
| NCT01142128 | Chronic Pancreatitis | Phase 1 | Terminated(Viokase was taken o... More >>ff market during study and remained off over a year.) Less << | - | United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less << |
| NCT01142128 | - | Terminated(Viokase was taken o... More >>ff market during study and remained off over a year.) Less << | - | - | |
| NCT02659683 | Healthy Subjects | Phase 1 | Completed | - | - |
| NCT02477475 | - | Completed | - | Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less << | |
| NCT00637845 | Heartburn Gas... More >>troesophageal Reflux Disease Less << | Phase 4 | Completed | - | - |
| NCT01135472 | Healthy | Phase 1 | Completed | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less << |
| NCT00658775 | - | Completed | - | - | |
| NCT00658775 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 3 | Completed | - | - |
| NCT00658632 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 3 | Completed | - | - |
| NCT00658632 | - | Completed | - | - | |
| NCT00658528 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 3 | Completed | - | - |
| NCT00658528 | - | Completed | - | - | |
| NCT02479581 | Valvular Heart Disease | Phase 2 | Completed | - | China, Hunan ... More >> Xiangya Hospital of Central South University Changsha, Hunan, China, 410078 Less << |
| NCT00464308 | Gastro-oesophageal Reflux | Phase 4 | Completed | - | Australia ... More >> Belconnen, Australia Bondi Junction, Australia Brookvale, Australia Browns Plains, Australia Campbelltown, Australia Campsie, Australia Caringbah, Australia Castle Hill, Australia Charlestown, Australia Dapto, Australia Darlinghurst, Australia Dubbo, Australia Elizabeth, Australia Fairfield, Australia Hoppers Crossing, Australia Ingleburn, Australia Leichhardt, Australia Maroubra, Australia Melton, Australia Mount Druitt, Australia Oaklands Park, Australia Royal Park, Australia Sydney, Australia Wentworthville, Australia Wyoming, Australia Less << |
| NCT03600974 | - | Not yet recruiting | July 1, 2021 | - | |
| NCT00464308 | - | Completed | - | - | |
| NCT03452865 | Sepsis Septic... More >> Shock Less << | Phase 3 | Not yet recruiting | June 2022 | Italy ... More >> IRCCS San Raffaele Scientific Institute Not yet recruiting Milan, MI, Italy, 20132 Contact: Giacomo Monti, MD +39 022643 2222 monti.giacomo@hsr.it Less << |
| NCT00857597 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | Phase 3 | Terminated(Study was terminate... More >>d after unplanned interim analysis of single centre data and results were reported) Less << | - | Netherlands ... More >> University Hospital Maastricht Maastricht, Limburg, Netherlands, 6229 HX Less << |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.72mL 0.54mL 0.27mL |
13.61mL 2.72mL 1.36mL |
27.22mL 5.44mL 2.72mL |
|
| Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
|||